WESTFORD, Mass., May 4, 2011 /PRNewswire/ -- Cynosure, Inc.
(NASDAQ: CYNO), a leader in laser- and light-based treatments for
minimally invasive and non-invasive aesthetic applications, today
announced that it will present at the following investor
conferences in May:
- On Tuesday, May 10 at
3:30 p.m. (ET), President and CEO
Michael Davin and Timothy Baker, the company's executive vice
president, treasurer and CFO, will present at the Tenth Annual JMP
Securities Research Conference in San
Francisco.
- On Monday, May 16 at
3:30 p.m. (ET), Mr. Davin and Mr.
Baker will present at the Noble Financial Capital Markets "SEVEN"
seventh annual equity conference in Hollywood, Florida.
Investors can hear live audio webcasts of these presentations,
as well as archived replays of the events, on the Investor
Relations section of the Company's website, www.cynosure.com
About Cynosure, Inc.
Cynosure, Inc. develops and markets aesthetic treatment systems
that are used by physicians and other practitioners to perform
non-invasive and minimally invasive procedures to remove hair,
treat vascular and pigmented lesions, rejuvenate the skin, liquefy
and remove unwanted fat through laser lipolysis and reduce the
appearance of cellulite. Cynosure's products include a broad
range of laser and other light-based energy sources, including
Alexandrite, pulse dye, Nd:YAG and diode lasers, as well as intense
pulsed light. Cynosure was founded in 1991. For corporate or
product information, contact Cynosure at 800-886-2966, or visit
www.cynosure.com.
Contact:
Scott Solomon
Vice President
Sharon Merrill Associates, Inc.
617.542.5300
cyno@investorrelations.com
SOURCE Cynosure, Inc.